| Particulars |
|
|
|
| Company Name
| Beryl Drugs Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
5.07 |
B.V. (₹) |
18.60 |
| Sales(₹ Cr.) |
21.15 |
NP (₹ Cr.) |
0.58 |
| NP Var (%) |
-24.00 |
Div% |
0.00 |
| CPS(₹) |
3.60 |
EPS (₹) |
1.10 |
| Traded Value(₹ Lakhs) |
0.36 |
52 Week High |
44.00 |
| 52 Week Low |
17.00 |
Price BSE |
23.00 |
| Price NSE |
0.00 |
Market Capital (₹ Cr.) |
11.66 |
| P/C Ratio |
6.40 |
P/E Ratio |
20.20 |
| Price Vs.BV |
1.24 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
5.12 |
| NP(₹ Cr.) |
0.01 |
NP Var % |
29.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
22.46 |
| OPM |
10.57 |
NP |
0.34 |
| NP Var (%) |
-30.90 |
EPS |
0.46 |
| PE |
50.00 |
|
|